Related Experiment Video
Updated: Jul 31, 2025

A Simple and Inexpensive Method for Determining Cold Sensitivity and Adaptation in Mice
Published on: March 17, 2015
Structural mechanisms of TRPM7 activation and inhibition
Kirill D Nadezhdin1, Leonor Correia2, Chamali Narangoda3
1Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA.
Abstract:
The transient receptor potential channel TRPM7 is a master regulator of the organismal balance of divalent cations that plays an essential role in embryonic development, immune responses, cell mobility, proliferation, and differentiation. TRPM7 is implicated in neuronal and cardiovascular disorders, tumor progression and has emerged as a new drug target. Here we use cryo-EM, functional analysis, and molecular dynamics simulations to uncover two distinct structural mechanisms of TRPM7 activation by a gain-of-function mutation and by the agonist naltriben, which show different conformational dynamics and domain involvement. We identify a binding site for highly potent and selective inhibitors and show that they act by stabilizing the TRPM7 closed state. The discovered structural mechanisms provide foundations for understanding the molecular basis of TRPM7 channelopathies and drug development.
Insights
Transient receptor potential channel TRPM7 (Transient Receptor Potential Melastatin 7) regulates cation balance and is crucial for development and disease. This study reveals TRPM7 activation mechanisms and identifies a novel inhibitor binding site.
Area of Science:
- Biophysics
- Molecular Biology
- Structural Biology
Background:
- Transient receptor potential channel TRPM7 (Transient Receptor Potential Melastatin 7) is vital for divalent cation homeostasis.
- TRPM7 dysfunction is linked to embryonic development, immune responses, cell mobility, proliferation, differentiation, neuronal and cardiovascular disorders, and tumor progression.
- TRPM7 is recognized as a significant drug target for various diseases.
Purpose of the Study:
- To elucidate the structural mechanisms underlying TRPM7 activation by a gain-of-function mutation and the agonist naltriben.
- To identify a binding site for potent and selective TRPM7 inhibitors.
- To provide a structural basis for understanding TRPM7 channelopathies and guiding drug development.
Main Methods:
- Cryo-electron microscopy (cryo-EM) for high-resolution structural determination.
- Functional assays to assess channel activity and inhibitor efficacy.
- Molecular dynamics simulations to explore conformational dynamics.
Main Results:
- Two distinct structural mechanisms of TRPM7 activation were uncovered, involving different conformational dynamics and domain participation.
- A binding site for potent and selective TRPM7 inhibitors was identified.
- Inhibitors were shown to stabilize the closed state of the TRPM7 channel.
Conclusions:
- The study reveals novel structural insights into TRPM7 activation and inhibition.
- Understanding these mechanisms is crucial for developing targeted therapies for TRPM7-related disorders.
- The identified inhibitor binding site offers a promising avenue for TRPM7-targeted drug discovery.
Related Concept Videos
Mechanically-gated Ion Channels
Thermosensation
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Repressible Operon: trp Operon
G-Protein Gated Ion Channels
Sensory...

